172 related articles for article (PubMed ID: 33965490)
1. ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy.
Li H; Zhuang S; Yang Y; Zhou F; Rong J; Zhao J
Int J Biol Macromol; 2021 Jul; 183():839-851. PubMed ID: 33965490
[TBL] [Abstract][Full Text] [Related]
2. A core/shell stabilized polysaccharide-based nanoparticle with intracellular environment-sensitive drug delivery for breast cancer therapy.
Wu Y; Zhang X; Li H; Deng P; Li H; He T; Rong J; Zhao J; Liu Z
J Mater Chem B; 2018 Nov; 6(41):6646-6659. PubMed ID: 32254873
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
[TBL] [Abstract][Full Text] [Related]
4. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
5. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.
Zhou H; Fan Z; Deng J; Lemons PK; Arhontoulis DC; Bowne WB; Cheng H
Nano Lett; 2016 May; 16(5):3268-77. PubMed ID: 27057591
[TBL] [Abstract][Full Text] [Related]
8. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Yang H; Tang C; Yin C
Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
[TBL] [Abstract][Full Text] [Related]
9. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
10. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
Haque ST; Islam RA; Gan SH; Chowdhury EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
[No Abstract] [Full Text] [Related]
11. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
12. Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan.
Qiao F; Jiang Z; Fang W; Sun J; Hu Q
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806347
[TBL] [Abstract][Full Text] [Related]
13. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
[TBL] [Abstract][Full Text] [Related]
14. Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy.
Zhang X; Niu S; Williams GR; Wu J; Chen X; Zheng H; Zhu LM
Carbohydr Polym; 2019 Oct; 221():84-93. PubMed ID: 31227170
[TBL] [Abstract][Full Text] [Related]
15. Simply constructed chitosan nanocarriers with precise spatiotemporal control for efficient intracellular drug delivery.
Kong M; Zuo Y; Wang M; Bai X; Feng C; Chen X
Carbohydr Polym; 2017 Aug; 169():341-350. PubMed ID: 28504154
[TBL] [Abstract][Full Text] [Related]
16. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
17. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of quercetin-loaded hyaluronic acid-conjugated pH/redox dual-stimuli responsive poly(methacrylic acid)/mesoporous organosilica nanoparticles for breast cancer targeted therapy.
Ghalehkhondabi V; Soleymani M; Fazlali A
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130168. PubMed ID: 38365162
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ
Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
